Novartis has shared favorable initial findings from the APPULSE-PNH study, a Phase IIIB trial that assesses the effectiveness and safety of the twice-daily oral drug Fabhalta (iptacopan) for adults with paroxysmal nocturnal hemoglobinuria (PNH) who previously underwent anti-C5 therapies. Post […]
The United States Food and Drug Administration has accepted AstraZeneca’s supplemental Biologics License Application (sBLA) for Imfinzi (durvalumab), providing it Priority Review status for muscle-invasive bladder cancer (MIBC) treatment. The FDA assigns Priority Review to drug applications that, if approved,
The Karnataka State Registered Pharmacists Association (KSRPA) has urged the government to install an IAS officer in the leadership of the drugs control department by establishing a new non-technical administrative position. “For over ten years, we have been advocating for
KSRPA Advocates for IAS Leadership in State’s Drugs Control Department Read More »
Indian Medicines Pharmaceutical Corporation Limited (IMPCL), a Central Public Sector Enterprise (CPSE) earmarked for divestment by the government, has seen its asset valuation expand by 80% over the past five years, reaching the fiscal year 2023-24. IMPCL’s net worth climbed
IMPCL’s Asset Valuation Expands by 80% Over Five Years Read More »
Dr. Uday Saxena emphasized that the framework for conducting oncology clinical trials is maturing, thereby hastening the delivery of superior drugs to Indian patients over the coming decade. India is experiencing significant progress in cancer medication and treatment innovation, remarked
A growing interest in cost-effective respiratory solutions is being observed in both urban and rural sectors nationwide, spurred by an enhanced understanding of respiratory health post-Covid-19, according to a sector specialist. Suhas Shubhakaran, the co-founder of Oxymed under Karnataka-based Medequip
Increased Interest in Low-Cost Respiratory Solutions Noted by Industry Professional Read More »
Mesoblast Limited, a leader in cellular medicine for inflammatory conditions, has revealed that the US FDA has awarded their allogeneic stromal cell therapy, Revascor (rexlemestrocel-L), the Regenerative Medicine Advanced Therapy (RMAT) designation. This follows promising outcomes from a trial centered
The Ministry of Chemicals and Fertilisers highlights the significance of nafithromycin, India’s inaugural native macrolide antibiotic, which is currently pending final authorization from the Central Drugs Standard Control Organization (CDSCO). This breakthrough represents a monumental moment in tackling antimicrobial resistance,
Ministry Announces India’s Indigenous Antibiotic to Combat AMR Read More »
Traya, India’s pioneering health-tech company focusing on internal solutions for hair loss, released groundbreaking findings from an unprecedented clinical study comparing the effectiveness of Traya’s hair loss regimen to minoxidil, a widely used treatment, in addressing hair loss issues. This
The Ministry of Health and Family Welfare has challenged recent reports claiming an alleged scarcity of tuberculosis medications in India, describing such assertions as false and misleading. As of December 6, 2024, the National Tuberculosis Elimination Programme (NTEP) boasts over
Ample Supply of TB Medications, Affirms Health Ministry Read More »